Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy

Arsenic trioxide (ATO) is one of the first-line chemotherapeutic drugs for acute promyelocytic leukemia. Its anti-cancer activities against various human neoplastic diseases have been extensively studied. However, the clinical use of ATO for solid tumors is limited, and these limitations are because...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mengzhen, Zhang, Yanwen, Fang, Meirong, Jehan, Shah, Zhou, Wenhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026299/
https://www.ncbi.nlm.nih.gov/pubmed/35456577
http://dx.doi.org/10.3390/pharmaceutics14040743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026299/
https://www.ncbi.nlm.nih.gov/pubmed/35456577
http://dx.doi.org/10.3390/pharmaceutics14040743

Ejemplares similares